We found that eight genes, SLC10A7, ASPRV1, ZNF382, CDC42EP5, GPX3, STYK1, TGFB2, and PLOD2, were significantly associated with the chemotherapeutic effect of GC on CTRP. This evidence concerns the gene PLOD2 and gastric cancer.